Non-invasive alternative for phosphodiesterase inhibitor-refractory erectile dysfunction: Real-life experience with low-intensity extracorporeal shockwave therapy.

Medicine (Baltimore) · 2023 · PMC10637505 · PMID 37960801

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significanceP = .14not close (p > 0.1)

However, Group 1, while demonstrating a slight increase from 5.8 ± 1.47 to 6.1 ± 3.2 post-therapy, did not reach statistical significance ( P = .14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.